X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/novartis-touts-more-late-stage-data-for-inclisiran-the-once-centerpiece-heart-drug-spurned-by-the-fda/
https://endpts.com/novartis-9-7b-pcsk9-drug-nabs-first-ok-now-comes-the-challenge-of-finding-a-market/
http://www.pmlive.com/pharma_news/novartis_picks_up_inclisiran_after_completion_of_medco_acquisition_1321708
https://www.globenewswire.com/news-release/2020/01/06/1966217/0/en/Novartis-completes-tender-offer-for-all-outstanding-shares-of-The-Medicines-Company.html
https://www.globenewswire.com/news-release/2020/01/06/1966217/0/en/Novartis-completes-tender-offer-for-all-outstanding-shares-of-The-Medicines-Company.html
https://www.globenewswire.com/news-release/2020/01/06/1966217/0/en/Novartis-completes-tender-offer-for-all-outstanding-shares-of-The-Medicines-Company.html
https://www.fiercepharma.com/pharma/9-7b-too-much-for-medicines-company-purchase-novartis-itself-appears-to-think-so
https://www.biospace.com/article/novartis-to-buy-the-medicines-company-for-9-7-billion/
https://www.businesswire.com/news/home/20191116005001/en/Medicines-Company-Announces-ORION-10-Study-Inclisiran-ASCVD
Market Place
Share 
